Wiskott–Aldrich syndrome: diagnosis, current management, and emerging treatments
نویسندگان
چکیده
منابع مشابه
Wiskott–Aldrich syndrome: diagnosis, current management, and emerging treatments
Wiskott-Aldrich syndrome (WAS) is a rare X-linked primary immunodeficiency disorder characterized by the triad of eczema, thrombocytopenia, and severe and often recurrent infections. Despite the rarity of this disorder, our understanding of the molecular and cellular pathogenesis of WAS has continued to increase. Advances in the use of diagnostic tools, the provision of supportive care, and imp...
متن کاملCurrent and emerging treatments for the management of osteogenesis imperfecta
Osteogenesis imperfecta (OI) is the most common bone genetic disorder and it is characterized by bone brittleness and various degrees of growth disorder. Clinical severity varies widely; nowadays eight types are distinguished and two new forms have been recently described although not yet classified. The approach to such a variable and heterogeneous disease should be global and therefore multid...
متن کاملCurrent and emerging treatments for the management of myasthenia gravis
Myasthenia gravis is an autoimmune neuromuscular disorder. There are several treatment options, including symptomatic treatment (acetylcholinesterase inhibitors), short-term immunosuppression (corticosteroids), long-term immunosuppression (azathioprine, cyclosporine, cyclophosphamide, methotrexate, mycophenolate mofetil, rituximab, tacrolimus), rapid acting short-term immunomodulation (intraven...
متن کاملPelvic Congestion Syndrome: Current Diagnosis and Management
Pelvic Congestion Syndrome (PCS) is a common concern for premenopausal, multiparous women with chronic pelvic pain persisting greater than 6 months. It is defined as observable congestion of pelvic veins due to pelvic varicosities that cause reflux and dilation of ovarian veins, resulting in venostasis [1,2]. Although the etiology is unknown, PCS is associated with anterior, posterior or circum...
متن کاملCurrent and emerging treatments for brain metastases.
Brain metastasis in patients with cancer can be indicative of multisystem spread or lead to neurological demise if not locally controlled, and is associated with poor survival and high morbidity. Compared with metastasis to other areas of the body, brain metastasis possesses a unique biology that confers high resistance to systemic therapies. This phenomenon has been historically attributed to ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The Application of Clinical Genetics
سال: 2014
ISSN: 1178-704X
DOI: 10.2147/tacg.s58444